[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Views 463
Citations 0
Research Letter
June 9, 2021

Cost of Treatment of Benign and Premalignant Lesions During Skin Cancer Screening

Author Affiliations
  • 1Department of Dermatology, Northwestern University, Chicago, Illinois
  • 2Department of Dermatology, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania
  • 3Department of Dermatology, University of Utah, Salt Lake City
  • 4Department of Medicine, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania
JAMA Dermatol. Published online June 9, 2021. doi:10.1001/jamadermatol.2021.1953

To date, cost analyses of skin cancer detection and screening via total body skin examination (TBSE) have primarily focused on the costs of the visit, skin biopsies, and pathologic assessment of lesions.1,2 However, in addition to skin cancers, premalignant actinic keratoses (AKs) and benign lesions (acrochordons, verruca vulgaris, and seborrheic keratoses [SKs]) are likely to be identified and treated during TBSEs. Factoring in the costs of treating these lesions during skin cancer screening visits is important for evaluating the cost effectiveness of skin cancer screening in dermatology practices.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words